Skip to main content
Our Work

Examining the Impact of Real-World Evidence on Medical Product Development: A Workshop Series

Completed

Randomized, controlled clinical trials (RCTs) have traditionally served as the gold standard for evidence generation in support of medical product development and approval. However, it is increasingly recognized that RCTs have inherent limitations. This three-part workshop series provided a venue to examine the practicalities of collecting real-world data and deriving real-world evidence for evaluation of medical products. The workshop was convened by the Forum on Drug Discovery, Development, and Translation, and sponsored by the Food and Drug Administration.

Please visit the individual event pages (1-Incentives, 2-Practical Approaches, 3-Application) for workshop information & materials, and journal articles inspired the by series.

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.